TACkling Cancer by Targeting Selective Protein Degradation

Targeted protein degradation has emerged as an alternative therapy against cancer, offering several advantages over traditional inhibitors. The new degrader drugs provide different therapeutic strategies: they could cross the phospholipid bilayer membrane by the addition of specific moieties to extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Noblejas-López, María del Mar, Tébar-García, David, López-Rosa, Raquel, Alcaraz-Sanabria, Ana, Cristóbal-Cueto, Pablo, Pinedo-Serrano, Alejandro, Rivas-García, Lorenzo, Galán-Moya, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610449/
https://www.ncbi.nlm.nih.gov/pubmed/37896202
http://dx.doi.org/10.3390/pharmaceutics15102442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610449/
https://www.ncbi.nlm.nih.gov/pubmed/37896202
http://dx.doi.org/10.3390/pharmaceutics15102442

Ejemplares similares